BPC-157: What the Research Does and Doesn’t Show
Preclinical data is genuinely encouraging. Human data is thinner than most clinics will admit. An honest look at what the evidence supports.
Read articlePreclinical data is genuinely encouraging. Human data is thinner than most clinics will admit. An honest look at what the evidence supports.
Read articleThe term gets thrown around like a synonym for steroids, supplements, and hormones. It is not. A practical primer on what makes a peptide, and what makes peptide therapy different.
Read articleTitration, side effects, labs, and the honest timeline. What semaglutide and tirzepatide actually feel like in the first three months — and how to know if it is working.
Read articleThe category most patients get wrong. A practical guide to the regulatory landscape and why it matters for your care.
Read articleA plain-language explanation of 503A and 503B compounding, what these regulations mean for the peptides you receive, and how to evaluate whether your pharmacy meets quality standards.
Read articleGHRH/GHRP peptides raise growth hormone. They do not reverse aging. An honest look at what GH-axis support can and cannot do.
Read articleHow to evaluate the evidence behind peptide claims. The questions that separate signal from noise in a field full of overstated marketing.
Read articleAn honest list of peptides we choose not to offer, and the reasoning behind each decision. What we don’t do is as important as what we do.
Read articlePeptides amplify good biology. They cannot replace it. The honest truth about what your sleep, stress, and basic health habits do to your peptide therapy results.
Read articleA walkthrough of the baseline panel we order before starting peptide therapy. What each test tells us, what we do with the results, and why we never skip this step.
Read article